Placebo matching BI 3031185

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

CompletedNCT06255340

Boehringer IngelheimHealthy

Start: 2024-03-11End: 2024-08-28Updated: 2024-11-13

A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

SuspendedNCT07656792

Boehringer IngelheimHealthy

Start: 2026-07-17End: 2026-11-26Target: 36Updated: 2026-08-19